EQT Fund Management S.a r.l. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001834239

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedTechnology Tilt how tags are computed

Q2 2026 · 5 positions · Total reported value $862.62M · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 16.7% · 1 new · 0 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, EQT Fund Management S.a r.l. disclosed 5 equity positions with a combined reported value of $862.62M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Technology Tilt.

The largest disclosed positions as of Q2 2026 were WAY ($510.77M), PHVS ($118.42M), OCS ($96.40M). By sector, the heaviest allocations are Technology 59.2%, Health Care 40.8%.

Versus the prior quarter, EQT Fund Management S.a r.l. opened 1 new positions, trimmed 0 and fully exited 0, a turnover rate of 16.7% of positions. The portfolio's overlap with the prior quarter was 100% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

Insider Transactions (Form 4)

Latest EQT Fund Management S.a r.l. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

EQT Fund Management S.a r.l. files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 5 positions worth $862.62M in total. HoldingsHub carries 4 quarters of its filings (Q3 2025–Q2 2026).

Portfolio Structure

  • 5 positions · $862.62M reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: WAY (WAYSTAR HLDG CORP) at 59.2%
  • Average position size: $172.52M

Sector Tilt

  • Information Technology 59.2%
  • Health Care 40.8%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 2 added
  • 3 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: EQT Fund Management's rebalancing in Q2 2026 appears to be conservative, with a focus on maintaining current positions and selectively adding to certain healthcare companies. This suggests a cautious approach, possibly reflecting market uncertainty or a preference for stable, long-term investments. 2. Key Moves: - Added: OCS (OCULIS HOLDING AG) by 17.8% and EVMN (EVOMMUNE INC) by 7.3%. These additions indicate a potential interest in the biotech and healthcare sectors. - Reduced: None noted. - Hold: The majority of holdings were held steady, including WAY (WAYSTAR HLDG CORP), PHVS (PHARVARIS N V), and AGMB (AGOMAB THERAPEUTICS NV). 3. Portfolio Structure: - Passive/Active: The portfolio seems to lean towards a passive strategy, as indicated by the "Hold" action on most positions and the lack of significant changes in portfolio composition. - Sector Bias: There is a clear bias towards the healthcare sector, with three out of the top five holdings in this sector. - Risk Appetite: The conservative approach with a focus on healthcare suggests a moderate risk appetite, balancing the potential for growth with a preference for stability. 4. Per-Holding One-Liner: - WAY (WAYSTAR HLDG CORP): Technology company focused on software solutions. - PHVS (PHARVARIS N V): Biotechnology company developing therapies for rare genetic disorders. - OCS (OCULIS HOLDING AG): Biotechnology company developing treatments for eye diseases. - EVMN (EVOMMUNE INC): Biotechnology company focused on the development of cancer immunotherapies. - AGMB (AGOMAB THERAPEUTICS NV): Biotechnology company focusing on the development of antibody-based therapies for cancer and other diseases. - Unverified: None. 5. One-Sentence Style Summary: EQT Fund Management maintained a conservative stance in Q2 2026, focusing on stability with a selective expansion in the healthcare sector, reflecting a cautious yet strategic approach to investment.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Technology 59.2%
Health Care 40.8%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 24.88M $510.77M 59.21%
59.21%
Hold
2 3.42M $118.42M 13.73%
13.73%
Hold
3 6.95M $96.40M 11.18%
11.18%
Add
4 5.29M $70.28M 8.15%
8.15%
Add
5 5.14M $66.74M 7.74%
7.74%
Hold

FAQ

What did EQT Fund Management S.a r.l. buy in 2026-Q2?

In its 2026-Q2 13F filing, EQT Fund Management S.a r.l. reported 5 equity positions worth $862.62M in aggregate; its largest disclosed positions were WAY ($510.77M), PHVS ($118.42M), OCS ($96.40M).

How large is EQT Fund Management S.a r.l.'s portfolio?

EQT Fund Management S.a r.l. reported $862.62M of long equity holdings across 5 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is EQT Fund Management S.a r.l.'s investment style?

HoldingsHub classifies the portfolio as Small / Focused / Technology Tilt, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/eqt-fund-management-s-a-r-l/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →